MERCURY LABORATORIES
Back to Cashflow Statement
|
MERCURY LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹2.45 Cr | ₹5.19 Cr | ₹8.21 Cr | ₹5.49 Cr | ₹5.22 Cr |
What is the latest Cash Flow from Operating Activities ratio of MERCURY LABORATORIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹2.45 Cr |
Mar2022 | ₹5.19 Cr |
Mar2021 | ₹8.21 Cr |
Mar2020 | ₹5.49 Cr |
Mar2019 | ₹5.22 Cr |
How is Cash Flow from Operating Activities of MERCURY LABORATORIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹2.45 Cr | -52.75 | |
Mar2022 | ₹5.19 Cr | -36.83 | |
Mar2021 | ₹8.21 Cr | 49.54 | |
Mar2020 | ₹5.49 Cr | 5.15 | |
Mar2019 | ₹5.22 Cr | - |
Compare Cash Flow from Operating Activities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹104.4 Cr | -0.6% | 5.2% | 44% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -0.6% |
5.2% |
44% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses